Health Care & Life Sciences » Pharmaceuticals | Shin Poong Pharmaceutical Co. Ltd.

Shin Poong Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
10,556
8,409
16,291
40,997
38,178
66,589
Total Accounts Receivable
145,812
156,688
156,369
151,926
132,773
115,793
Inventories
43,467
43,946
45,429
42,207
46,929
44,938
Other Current Assets
474
2,279
768
649
949
1,463
Total Current Assets
200,309
211,321
218,857
235,778
218,828
228,782
Net Property, Plant & Equipment
161,697
159,941
152,192
144,269
138,192
130,505
Total Investments and Advances
13,325
17,349
23,210
17,929
17,491
10,097
Long-Term Note Receivable
-
-
-
1,950
-
-
Intangible Assets
15,951
14,589
12,174
11,275
8,784
6,809
Other Assets
1,816
1,810
-
300
1,778
2,152
Total Assets
403,071
415,348
415,612
420,245
394,940
385,129
ST Debt & Current Portion LT Debt
114,236
147,155
151,620
113,387
103,015
Accounts Payable
21,600
19,467
17,195
15,905
25,175
Income Tax Payable
3,702
2,226
438
4,288
181
Other Current Liabilities
13,094
11,661
14,993
33,437
10,704
Total Current Liabilities
152,632
180,509
184,245
167,018
139,076
Long-Term Debt
30,114
9,834
4,473
8,050
9,550
Provision for Risks & Charges
23,298
26,293
25,997
23,521
25,552
Deferred Taxes
5,258
4,285
4,298
4,987
5,556
Other Liabilities
1,526
1,145
1,153
1,051
1,323
Total Liabilities
212,286
223,833
220,751
203,396
179,811
Common Equity (Total)
190,497
191,213
194,556
216,545
214,830
Total Shareholders' Equity
190,497
191,213
194,556
216,545
214,830
Total Equity
190,785
191,514
194,861
216,849
215,129
Liabilities & Shareholders' Equity
403,071
415,348
415,612
420,245
394,940
Accumulated Minority Interest
288
302
305
303
300

About Shin Poong Pharmaceutical Co.

View Profile
Address
7 Wonsi-ro
Ansan-si GY 15610
Korea, Republic Of
Employees -
Website http://www.shinpoong.co.kr
Updated 07/08/2019
Shinpoong Pharmaceutical Co. Ltd. engages in the manufacture and sales of pharmaceutical products. Its products include joint function enhancers, antiinflammatory analgesic drugs, antibiotics, medicine for high blood pressure, and others. The company was founded on June 5, 1962 and is headquartered in Ansan-si, South Korea.